|

Calcium Folinate Clinical Trials

8 actively recruiting trials across 1 location

No change since May 2026

Also known as: LV, Leucovorin

Pipeline

Phase 1: 1Phase 2: 5Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Zhejiang Doer Biologics Co., Ltd.1
  • Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1
  • R-Pharm1
  • Nizhny Novgorod Regional Clinical Oncology Center1
  • Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1

Indications

  • Cancer8
  • Metastatic Colorectal Cancer2
  • Resectable Colon Cancer1
  • MSI-H/dMMR Colorectal Cancer1
  • Pancreatic Cancer Metastatic to Liver1

Other7 trials

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
Phase 1
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
Phase 2
Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
Phase 2
Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer
Phase 2
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
Phase 2
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Phase 1/2
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Phase 3

Stanford, California1 trial

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Local Institution - 307

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.